Form 4: Amdocs Executive Matthew Smith Sells Ordinary Shares

Matthew E. Smith, Secretary and Head of Investor Relations at Amdocs Ltd, disposed of 464 shares at a price of $62.51 per share.

Summary

• Matthew E. Smith sold 464 ordinary shares on May 29, 2026.
• The transaction was executed at a price of $62.51 per share.
• The total value of the sale amounted to approximately $29,004.64.
• Following the transaction, the reporting person still directly owns ,1550 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is small in dollar value and volume, likely representing routine personal financial activity rather than a strategic shift.

Positives

• The reporting person retains a majority of their holdings, keeping 1,550 shares after the sale.
• The sale represents a relatively small portion of the executive's total position, suggesting it may be for personal liquidity or diversification rather than a lack of confidence.

Negatives

• Insider selling can sometimes be interpreted by the market as a signal that the stock may be fully valued at current levels.

Risks

• No specific business or operational risks were disclosed in this transaction-focused report.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this ownership disclosure.

Industry Context

StockSavvy.ai notes that insider transactions by high-level executives like the Head of Investor Relations are closely watched for sentiment, though small-scale sales are often routine and part of pre-planned financial management.

Comparison to Industry Standards

• The transaction size is modest compared to typical large-cap executive sell-offs.
• The retention of over 75% of the prior holding is consistent with standard corporate governance expectations for executive skin-in-the-game.

Related Party Transactions

• The sale of 464 shares by Matthew E. Smith to the open market at $62.51 per share.

Stakeholder Impact

• Minimal impact on shareholders due to the low volume of shares traded relative to the company's total market capitalization.

Next Steps

• Monitor for further insider transactions that might indicate a broader trend among the management team.

Key Dates

Recommendation

The insider sale is too small to warrant a change in investment thesis. Investors should maintain their current positions while awaiting broader fundamental performance updates from the company.

Keywords

Amdocs Ltd, DOX, Insider Selling, Matthew E. Smith, SEC Form 4, Ordinary Shares, Investor Relations